635 KEYNOTE-495/KeyImPaCT: updated analysis of a biomarker-directed, randomized, phase 2 trial of pembrolizumab-based combination therapy for non-small cell lung cancer

Authors :: Roy Herbst
Wei-Sen Lam
Matthew Hellmann
Matthew Gubens
Charu Aggarwal
Daniel Shao Weng Tan
Enriqueta Felip
Joanne Chiu
Jong-Seok Lee
James Chih-Hsin Yang
Edward Garon
Giovanna Finocchiaro
Myung-Ju Ahn
Alexander Luft
Gregory Landers
Andrea Basso
Hua Ma
Julie Kobie
John Palcza
Razvan Cristescu
Lawrence Fong
Alexandra Snyder
Jianda Yuan
Martin Gutierrez
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Tools